Kalydeco now approved for expanded cystic fibrosis treatment
admin 7th June 2017 Uncategorised 0Pharmacy Times More: Kalydeco now approved for expanded cystic fibrosis treatment Source: MDlinx
read more
Pharmacy Times More: Kalydeco now approved for expanded cystic fibrosis treatment Source: MDlinx
read moreIt’s no secret that combination studies featuring checkpoint inhibitors and cancer vaccines have been popping up left and right. Now, an EP Vantage snapshot shows just how many trials are underway—and which drugmakers are leading the pack. More: BMS' Opdivo,
read moreThe Radboud University Medical Center in the Netherlands, the Instituto de Medicina Molecular Lisboa in Portugal, and PATH are collaborating on a human trial of a novel malaria vaccine. More: PATH, research institutes to test novel malaria vaccine in humans
read moreAlbany, New York-based AMRI has agreed to a buyout worth more than $920 million as the M&A market for contract manufacturers continues to run hot. The deal comes just weeks after one of the big boys among CDMO players, Patheon,
read moreThree years after appealing a €331 million ($373 million) fine from European antitrust authorities over a pay-for-delay deal on the blood pressure drug perindopril, Servier is getting its day in court. More: Three years later, Servier's €331M pay-for-delay appeal goes
read moreValeant Pharmaceuticals, on a mission to raise cash and pay down debt, is in talks to sell its Bausch & Lomb eye surgery business to Germany-based Carl Zeiss Meditec, Finanzen reported, citing Bloomberg. More: Valeant, searching for cash, nears B
read more© 1994 - 2026 B.M. Pharmaceuticals